Navid Sobhani

Scientist, Ph.D.


Curriculum vitae


[email protected]


Department of Cancer Biology

UT MD Anderson Cancer Center



HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma


Journal article


Xiaoqing Shi, Jiage Ding, Yanyan Zheng, Jiawei Wang, Navid Sobhani, Praveen Neeli, Gang Wang, unnian Zheng, Dafei Chai
iScience, vol. 26(3), 2023, p. 106143


Cite

Cite

APA   Click to copy
Shi, X., Ding, J., Zheng, Y., Wang, J., Sobhani, N., Neeli, P., … Chai, D. (2023). HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma. IScience, 26(3), 106143. https://doi.org/10.1016/j.isci.2023.106143


Chicago/Turabian   Click to copy
Shi, Xiaoqing, Jiage Ding, Yanyan Zheng, Jiawei Wang, Navid Sobhani, Praveen Neeli, Gang Wang, unnian Zheng, and Dafei Chai. “HMGB1/GPC3 Dual Targeting Vaccine Induces Dendritic Cells-Mediated CD8+T Cell Immune Response and Elicits Potential Therapeutic Effect in Hepatocellular Carcinoma.” iScience 26, no. 3 (2023): 106143.


MLA   Click to copy
Shi, Xiaoqing, et al. “HMGB1/GPC3 Dual Targeting Vaccine Induces Dendritic Cells-Mediated CD8+T Cell Immune Response and Elicits Potential Therapeutic Effect in Hepatocellular Carcinoma.” IScience, vol. 26, no. 3, 2023, p. 106143, doi:10.1016/j.isci.2023.106143.


BibTeX   Click to copy

@article{xiaoqing2023a,
  title = {HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma},
  year = {2023},
  issue = {3},
  journal = {iScience},
  pages = {106143},
  volume = {26},
  doi = {10.1016/j.isci.2023.106143},
  author = {Shi, Xiaoqing and Ding, Jiage and Zheng, Yanyan and Wang, Jiawei and Sobhani, Navid and Neeli, Praveen and Wang, Gang and unnian Zheng and Chai, Dafei}
}


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in